pentobarbital will decrease the extent or outcome of lumefantrine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with potent CYP3A4 inducers may lead to lessened serum concentrations and lack of antimalarial efficacypentobarbital will lessen the extent or result of dienogest/estradiol valerate by impacti… Read More